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Abstract
Background: Publication of ethically uncertain research occurs despite well-published guidelines set forth in
documents such as the Declaration of Helsinki. Such guidelines exist to aide editorial staff in making decisions
regarding ethical acceptability of manuscripts submitted for publication, yet examples of ethically suspect and
uncertain publication exist. Our objective was to survey journal editors regarding practices and attitudes
surrounding such dilemmas.
Methods: The Editor-in-chief of each of the 103 English-language journals from the 2005 Abridged Index Medicus
list publishing original research were asked to complete a survey sent to them by email between September-
December 2007.
Results: A response rate of 33% (n = 34) was obtained from the survey. 18% (n = 6) of respondents had published
ethically uncertain or suspect research within the last 10 years. 85% (n = 29) of respondents stated they would
always reject ethically uncertain articles submitted for publication on ethical grounds alone. 12% (n = 4) of
respondents stated they would approach each submission on a case-by-case basis. 3% (n = 1) stated they would
be likely to publish such research, but only with accompanying editorial. Only 38% (n = 13) give reviewers explicit
instruction to reject submissions on ethical grounds if found wanting.
Conclusions: Editorial compliance with the Declaration of Helsinki in rejecting research that is conducted
unethically was difficult to ascertain because of a poor response rate despite multiple attempts using different
modalities. Of those who did respond, the majority do reject ethically suspect research but few explicitly advise
reviewers to do so. In this study editors did not take advantage of the opportunity to describe their support for
the rejection of the publication of unethical research.
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Background
The first formal request to editors of biomedical jour-
nals by the American Medical Association in 1912 asked
them to “scrutinize carefully original papers submitted
for publication” in the context of compliance with prin-
ciples of medical ethics [1,2]. The Declaration of Hel-
sinki (DoH) in 1964 specifically addressed the issue of
publication when research is found lacking in any or all
of its recommended tenets; “both authors and publishers
have ethical obligations...reports of experimentation not
in accordance with the principles laid down in this
declaration should not be accepted for publication”[3,4].
Despite these regulations, attitudes and practices sur-
rounding the publication of ethically suspect research is
relatively understudied.
Though most editors and journals follow the tenets of
the DoH, publication of unethical research still occurs
[5,6]. Why its principles are not consistently complied
with is unclear. There is argument that not allowing for
flexibility in publication of ethically suspect research
does a disservice to both human participants and the
scientific community [7]. Some argue that non-publica-
tion engenders an unrealistic perception that unethical
research is not occurring [8]. Some biomedical journals
have chosen to publish ethically suspect research with
an accompanying editorial in hopes of fostering
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discussion of ethical challenges [9,10]. This is particu-
larly relevant when the issue is not clearly a breach of
established ethical conduct. Further argument for publi-
cation of ethically suspect research lies in the potential
loss of valuable scientific information, the risks assumed
by the research participants and the need to expose
further research participants to risk if the research is to
be replicated[8].
In 1977, a survey of 138 core medical journal editors
was administered by Brackbill and Hellegers regarding
whether or not they would personally or professionally
publish unethical research. The survey results were lim-
ited by a low response rate but indicated an apparent
consensus of opinion concerning editorial responsibility
to screen for and publish ethical research. This survey
predated the formation of agencies such as the Interna-
tional Commission of Medical Journal Editors (ICMJE),
which sets forth ethical guidelines regarding publication
[11]. In 1977 only a minority of journals required
authors to submit details regarding obtaining informed
consent or research ethics board (REB) approval and the
majority of editors did not instruct the reviewers to con-
sider ethical issues in their assessments of submitted
manuscripts [12,13]. Our primary objective, therefore,
was to survey editors of all 103 English language jour-
nals in the Abridged Index Medicus. We hoped to
describe modern era attitudes and practices with respect
to the publication of ethically suspect research.
Our hypotheses were: 1) Few journal editors would
accept ethically uncertain research for publication today,
2) Of those publishing ethically uncertain research, the
majority would indicate they would supply an accompa-
nying editorial, 3) Of those refusing to publish ethically
uncertain research a higher number of editors would
instruct their reviewers to screen for ethical violations,
and finally that 4) Editors would be more likely to pub-
lish individual case reports without meeting full ethical
requirements than clinical trials. We describe these
results and the implications of a relatively low response
rate with respect to the responsibility of editors to trans-
parently demonstrate compliance with the Declaration
of Helsinki.
Methods
All components of the study requiring contact with
human participants were approved by the IWK Health
Centre REB committee. The Editor-in-chief of each of
the 103 English-language journals from the 2005
Abridged Index Medicus list (last updated February
2005) publishing original research were asked to com-
plete a survey sent to them by email between Septem-
ber-December 2007. If the initial email was
unsuccessful, the non-responders were contacted by
phone to ensure correct electronic address and the
survey was resent. Email addresses and phone numbers
for editorial offices were attained via publicly available
resources. The Editor-in-chief was instructed to forward
the survey to an associate editor if (s)he felt it more
appropriate.
The 25 item survey was designed using the method of
Dillman[14]. It included a demographic section to
describe the population of respondents (see Table 1).
Questions were derived from a review of the literature
including the previous Brackbill survey in 1977 [12].
Our aim was to identify if and under what
Table 1 Demographics of respondents
Type of Journal: (n) (%)
General Medical 11 32
Subspecialty 23 68
Age Group: 10 29











Editorial Position Head: 32 94
Editor-In-Chief 2 6
Other
Length of time in Journal: 14 41








Education Held: 28 82
MD 8 23.5
PhD 4 12
Formal Bioethics Training 1 3
ICMJE 4 9
Other




Formal Bioethics Training: 13 38
Yes 21 62
No
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circumstances editors are willing to publish ethically
uncertain research. We also wanted to identify what edi-
tors perceived as “ethically uncertain”. Prior to adminis-
tration, the survey underwent a content validity exercise
with 8 experts in editorial work and research publication
and the survey modified accordingly. We also piloted
the survey with 8 physicians who had editorial and pub-
lication experience for length and readability. An
optional text box concluded the survey to allow respon-
dents a location to indicate whether they would like a
copy of the research results and also be included in our
book prize draw, which was used as an incentive to
encourage response. This information was kept confi-
dential and separate from the data. Statistical analysis
was by descriptive methods of frequency. Chi square
analysis was planned, with view to apply the Fisher
Exact test if sparse cells existed, but not conducted
given our low response rate.
Results
The response rate for completion of our survey was 33%
(n = 34). 6 potential respondents declined due to time
constraint. 11 potential respondents had out of date
contact information or unpublished email or phone
numbers. 52 potential respondents did not reply.
Repeated efforts were made to contact these potential
respondents who did not reply via email and telephone
over a 1 year period. Demographic characteristics of the
respondents are shown in Table 1.
When polled as to whether the editor had published
ethically uncertain research during their tenure as edi-
tor; 15% (n = 5) replied, “yes”, while 85% (n = 29) said
“no”. 85% (n = 29) of respondents stated that they
would always reject ethically uncertain articles sub-
mitted for publication on ethical grounds alone. 3% (n =
1) indicated they would accept ethically uncertain
research for publication under certain circumstances but
always with an editorial to identify ethical issues. 12% (n
= 4) of respondents stated they would approach each
submission on a case-by-case basis and often refer ques-
tionable manuscripts and their authors back to the
Declaration of Helsinki. They also indicated that occa-
sionally they then would allow resubmission if identified
ethical issues had been satisfactorily addressed.
A Likert scale was used to identify primary reasons
editorial staff may consider publishing ethically uncer-
tain research (see Table 2). Reasons provided to reject
publication of ethically uncertain research were
explored; respondents could select more than one rea-
son. 82% (n = 28) of respondents either agreed or
strongly agreed that publishing ethically uncertain
research would not be in accordance with international
standards. 79% (n = 27) agreed or strongly agreed that
they would not publish such research in order to deter
its future submission. 85% (n = 29) felt they had a
responsibility to readers not to publish ethically uncer-
tain research. 62% (n = 21) felt that the quality of the
science would also be suspect when reviewing ethically
uncertain research submitted for publication.
The editors were then asked how often, within the last
5 years, they had: i) become aware of ethically uncertain
research upon reviewing manuscripts for publication ii)
Informed the author’s parent institution of submission
of ethically uncertain research, and iii) Informed the
author’s funding agency of ethically uncertain research if
submitted. The results can be found in Table 3. The
respondents indicated that the infractions most likely to
cause them to notify institutions or funding agencies
were: fraudulent data (88%; n = 30), duplicate publica-
tion (68%; n = 23), conduct without REB approval (50%;
n = 17), lack of consent obtained (50%; n = 17), “other”
breaches of the Declaration of Helsinki (50%; n = 17)
and disproportionate risks to research participants (44%;
n = 15). Only 12% (n = 4) indicated they would not
inform either the funding agency or the parent institu-
tion of ethical infractions noted upon review.
The majority of respondents indicated that they would
review various study designs with the same or greater
stringency when compared with that used to review a
phase III trial design (see Table 4). Editors were asked
what they viewed their primary role as; that of “rule-
maker”, “gate-keeper” or to promote discussion sur-
rounding ethically uncertain issues. 61% (n = 21) agreed
or strongly agreed that their role included that of “rule-
maker”. 89% (n = 31) agreed or strongly agreed that
their role included that of “gate-keeper”. 76% (n = 26)
believed they had a role to play in promoting discussion
surrounding ethically uncertain issues.
When asked if their journal instructed reviewers to
examine submitted manuscripts for adherence to applic-
able ethical regulatory guidelines, 70% (n = 24) indicated
they did. When asked if their journal instructed reviewers
to recommend rejection of a submitted manuscript on
the basis of lack of adherence to applicable ethical regula-
tory guidelines, 62% (n = 21) indicated they did not. We
asked editors to describe an incident of unethical
research to give an overview of common challenges.
Almost all editors, 79% (n = 27), replied with examples of
specific events with the majority citing duplicate publica-
tion or plagiarism and to a lesser degree risk to partici-
pants, justice issues and fabrication of data. Many editors
noted that they not only addressed this with the author
directly but also notified responsible institutions.
Discussion
Our study’s low response rate inhibits our ability to
draw robust conclusions. It demonstrates in the respon-
dents a high degree of consensus that editors would
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comply with the Declaration of Helsinki in rejecting
publication of ethically suspect research submitted for
review. This would seem to be consistent with the find-
ings of Brackbill and Hellegers published 30 years ago
but is similarly limited to by a relatively poor response
rate. We have attempted to identify the rationale given
by editors in considering rejection of ethically suspect
research. Those editors that did respond indicated that
deterrence to future submission of unethical research, a
desire to comply with international regulations and a
feeling of responsibility to the public and scientific com-
munity all play a roll in their decision to reject such
manuscripts.
Given the high degree that the responding editors
indicated they would not publish ethically suspect
research, one might expect that nearly all of the respon-
dents and their journals would specifically instruct
reviewers to examine submitted manuscripts for adher-
ence to applicable ethical regulatory guidelines and
indeed most do. We have corroborated this finding in a
separate study that directly examined instructions to
authors [15]. We further noted that just 38% (n = 13) of
journals would specifically instruct their reviewers to
reject manuscripts based on ethical grounds alone.
Again, we cannot draw a definitive conclusion but
believe this may be a lost opportunity to proactively har-
ness the strength of the scientific community in asses-
sing and recommending rejection of unethical research.
This could be rectified with relatively simple additions
within the instructions to reviewers.
In an editorial in the British Journal of Medicine in
2004, Fiona Godlee states that “editors have no man-
date” to govern their conduct [16]. Although agencies
such as the Committee on Publication Ethics (COPE)
and the World Association of Medical Editors (WAME)
have attempted to publish codes of conduct for editors
specifically, breeches of them are unenforceable as they
have no legal jurisdiction [17-19]. Such codes have been
in existence long before we conducted our survey.
Should we be encouraging mandatory membership of all
medical journals to a regulatory body that holds each
accountable? Or does this dissuade the high degree of
academic freedom that many editors enjoy?
Although editorial adherence to guidelines is encour-
aged and even expected, it remains variable how such
codes are interpreted and implemented. Godlee as one
of the founders of the first iterations of COPE guide-
lines, states that editors may be tempted to simply
refuse to publish a paper based on “other” (presumably
ethical) grounds alone [17]. COPE mandates that this
alone, is not appropriate and states that editors should
investigate all serious allegations fully so as editors take
their role as “guardians” of the biomedical literature ser-
iously [17]. Of interest, the majority of editors in our
survey will not only reject a paper on ethical grounds
but also take measures to inform the host institution
and/or funding agencies. This more specifically adheres
to the ICMJE, COPE and WAME recommendations on
how to approach such submitted research.
Editorial obligation is extensive. Do they have time to
act as “responsible social agents” and hold authors
accountable in all cases for possible ethical infractions
[19]? Once research misconduct is identified one may
argue that handing over responsibility to an agency
whose mandate it would be to deal with such allegations
would be a more efficient model. This may be reflected
by the 61% (n = 21) of respondents in our survey who
viewed themselves as “rule-makers” versus the higher
proportion of 89% (n = 31) who viewed themselves as
“gate-keepers”. By defining editorial obligation in














Would publish if value in data collected 21(62) 7(21) 4(12) 2(6)
Would publish to make it visible 25(74) 5(15) 3(9) 1(3)
Would publish for educatinal value of Collective Scrutiny 23(68) 4(12) 5(15) 2(6)
Would publish so risk to participants not recurrent 20(59) 9(26) 1(3) 4(12)
Would publish as some areas “grey” and warrant discussion 12(35) 11(32) 9(26) 2(6)
Table 3 Frequency of presentation of different scenarios













1. Became aware of ethically uncertain research upon rev. manuscript for publication? 5(15) 14(41) 8(24) 6(18) 1(3)
2. Informs the author’s parents inst. of submission of ethically uncertain research? 13(38) 14(41) 6(18) 1(3) 0(0)
3. Informed the author’s funding agency of ethically uncertain research if submitted? 29(85) 3(9) 1(3) 1(3) 0(0)
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publication, aforementioned agencies such as COPE,
ICMJE and WAME are serving as the foundation upon
which renewed calls to editors are sounded. There have
been efforts to re-examine consequences, such as impact
upon membership, by members who do not comply
with these guidelines [17]. Does this constrain editorial
freedom or ensure scientific accountability?
Limitations of our study include a relatively small
response rate. Although average response rates of email
surveys have been quoted at roughly 30%, we expected a
much higher return given the study content and sample
population [14]. It is distressing that editors did not
take the opportunity to publically share their editorial
practice in a transparent way. This we feel was a lost
opportunity to add transparency to the editorial process
of scientific review and therefore underpin public confi-
dence in the research enterprise. We theorize that
because editors often have many demands on their time,
the emailed survey may have been overlooked or deleted
without further attention. Given the importance of the
ethical questions raised, one should consider the impli-
cations such dismissal has on what is indeed published
within the medical literature. Is ethically suspect or con-
cerning material dissected appropriately at all times?
Attempts to rectify our response rate were made by
contacting editorial offices directly by telephone. This
was also a challenge as many editors would either not
respond to the call or fail to return our repeated
attempts at contacting them. We considered that non-
respondents were hesitant to participate in such a sur-
vey given potential responses having a high degree of
visibility within the bioethical community. This seems
unlikely given the number of respondents that consider
themselves ‘gatekeepers’ of the literature. The possibility
that responses were biased by social and editorial
acceptability, which may not reflect actual practice, may
have also impacted the results we obtained. We feel this
is unlikely however, given the confidential nature of the
survey, a typically strong sense of academic freedom in
individuals charged as editors and that editors-in-chief
intrinsically have positions that require a high degree of
integrity and accountability. Although there was editor-
ial representation from a variety of specialty and general
medical journals publishing original human research,
generalizability was compromised given our sample size.
Conclusions
In conclusion, we have found that responding editors
are reasonably consistent and compliant with the
Declaration of Helsinki in rejecting publication of ethi-
cally uncertain research. Editors seem to identify a
mixed understanding of their roles in research miscon-
duct oversight but for the most part play a strong role
in rejection of ethically suspect research and in notifying
appropriate institutions. Opportunity exists to
strengthen review of ethically suspect research by more
deliberately charging reviewers with the task of both
reviewing manuscripts with respect to compliance of
ethical tenets, and rejecting those that do not meet
applicable international standards. Editors should con-
sider adopting uniform practices when they do publish
ethically suspect research such as alerts to the reader
and/or editorial comment. Finally, the scientific commu-
nity must continue to define whom they are accountable
to so that ethical infractions continue to be dissuaded.
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